Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorso

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|September 21, 2001
Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1S Ahmad, L M Doweyko, S Dugar, et al.
Chemistry & Biology|September 1, 2009
Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureusJoann Huber, Robert G K Donald, Sang Ho Lee, et al.
Chemistry & Biology|October 13, 2015
Elucidation of DnaE as the Antibacterial Target of the Natural Product, NargenicinRonald E Painter, Gregory C Adam, Marta Arocho, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392R W Ratcliffe, R R Wilkening, K J Wildonger, et al.
Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2007
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesJun Wang, Srinivas Kodali, Sang Ho Lee, et al.
Chemistry & Biology|August 27, 2011
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureusJohn W Phillips, Michael A Goetz, Scott K Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Ezra Y Rosen, Malvika Sharma, et al.
Science (New York, N.Y.)|January 29, 1999
Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibioticH Rosen, R Hajdu, L Silver, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Malvika Sharma, Madeline A Dorso, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|September 21, 2001
Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1S Ahmad, L M Doweyko, S Dugar, et al.
Chemistry & Biology|September 1, 2009
Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureusJoann Huber, Robert G K Donald, Sang Ho Lee, et al.
Chemistry & Biology|October 13, 2015
Elucidation of DnaE as the Antibacterial Target of the Natural Product, NargenicinRonald E Painter, Gregory C Adam, Marta Arocho, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392R W Ratcliffe, R R Wilkening, K J Wildonger, et al.
Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2007
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesJun Wang, Srinivas Kodali, Sang Ho Lee, et al.
Chemistry & Biology|August 27, 2011
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureusJohn W Phillips, Michael A Goetz, Scott K Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Ezra Y Rosen, Malvika Sharma, et al.
Science (New York, N.Y.)|January 29, 1999
Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibioticH Rosen, R Hajdu, L Silver, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Malvika Sharma, Madeline A Dorso, et al.
Pageof 9